Cellectar Biosciences Inc
F:NV4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cellectar Biosciences Inc
F:NV4
|
US |
|
Boryszew SA
F:BOW
|
PL |
|
R
|
Romana Food Brands Corp
OTC:RFBC
|
US |
|
Q
|
Qingco Inc
OTC:QING
|
CN |
|
Sivota PLC
F:8ZB
|
UK |
|
M
|
Medcolcanna Organics Inc
F:MO2
|
CA |
|
Fluidra SA
MAD:FDR
|
ES |
|
K
|
Kimo Inc
OTC:KIMO
|
US |
Wall St Price Targets
NV4 Price Targets Summary
Cellectar Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
NV4 is 1.0355 EUR with a low forecast of 0.9922 EUR and a high forecast of 1.1347 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NV4's stock price target?
Price Target
1.0355
EUR
According to Wall Street analysts, the average 1-year price target for
NV4 is 1.0355 EUR with a low forecast of 0.9922 EUR and a high forecast of 1.1347 EUR.